Alyeska Investment Group
AHCO icon

Alyeska Investment Group’s AdaptHealth AHCO Stock Holding History

Alyeska Investment Group’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-199,831
Closed -$3.22M – 454
2020
Q2 		$3.22M Sell
199,831
-50,170
-20% -$838K 0.05% 313
2020
Q1 		$4M Hold
250,001
– – 0.08% 212
2019
Q4 		$2.75M Hold
250,001
– – 0.04% 272
2019
Q3 		$2.54M Hold
250,001
– – 0.04% 276
2019
Q2 		$275K Hold
250,001
– – ﹤0.01% 418
2019
Q1 		$2.5M Hold
250,001
– – 0.03% 270
2018
Q4 		$2.46M Hold
250,001
– – 0.04% 275
2018
Q3 		$370K Hold
250,001
– – ﹤0.01% 387
2018
Q2 		$2.4M Buy
+250,001
New +$2.43M 0.02% 339

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alyeska Investment Group's AHCO Position: Q2 2021 in Review

Alyeska Investment Group sold out of AdaptHealth (AHCO) in Q2 2021, closing a stake of 628,786 shares — an estimated $23.1M sold.

Alyeska Investment Group first reported a position in AHCO in Q2 2018 and held it in 11 quarters. The position peaked at $32.3M in Q3 2020. 137 funds tracked by Wall St. Rank hold AHCO as of Q2 2021.

  • Alyeska Investment Group reported no remaining AdaptHealth position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 628,786 AdaptHealth shares in Q2 2021, an estimated $23.1M.
  • Alyeska Investment Group first reported a position in AdaptHealth in Q2 2018 and held it in 11 quarters.
  • Alyeska Investment Group's AdaptHealth position peaked at $32.3M in Q3 2020.
  • 137 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.